CLO20-060: Factors Associated with the Uptake of Adjuvant Pertuzumab in Patients with Stage I-III HER2-positive Breast Cancer: The University of Colorado Cancer Center Experience

Authors:
Ericson Stoen University of Colorado Anschutz Medical Campus, Aurora, CO

Search for other papers by Ericson Stoen in
Current site
Google Scholar
PubMed Close
 MD
,
Jodi Kagihara University of Colorado Anschutz Medical Campus, Aurora, CO

Search for other papers by Jodi Kagihara in
Current site
Google Scholar
PubMed Close
 MD
,
Peter Kabos University of Colorado Anschutz Medical Campus, Aurora, CO

Search for other papers by Peter Kabos in
Current site
Google Scholar
PubMed Close
 MD
,
Christine Fisher University of Colorado Anschutz Medical Campus, Aurora, CO

Search for other papers by Christine Fisher in
Current site
Google Scholar
PubMed Close
 MD
, and
Jennifer R. Diamond University of Colorado Anschutz Medical Campus, Aurora, CO

Search for other papers by Jennifer R. Diamond in
Current site
Google Scholar
PubMed Close
 MD
Volume/Issue:
Volume 18: Issue 3.5
Online Publication Date:
20 Mar 2020
DOI:
https://doi.org/10.6004/jnccn.2019.7489
Restricted access

Corresponding Author: Ericson Stoen, MD
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2020 by the National Comprehensive Cancer Network 2020
Article Category:
Abstract
Print Publication Date:
20 Mar 2020
Online Publication Date:
20 Mar 2020

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 720 309 35
PDF Downloads 167 0 0
EPUB Downloads 0 0 0